REGENXBIO Inc. (RGNX)
Latest RGNX Insider Trades
About REGENXBIO Inc. (RGNX)
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
- ROCKVILLE, MD
- 371
- 2015
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 102,603 | $949K |
| Open-market sale | 3 | 58,494 | $718K |
| Grant or award | 22 | 595,108 |
RGNX Insider Transactions (Form 4)
5431 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gregory Austin Ciongoli - Director | Grant or award | Common Stock | 15,432 |
Recent RGNX Form 8-K Filings
5Recent RGNX Form 144 Notices of Proposed Sale
2A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - |
RGNX Insider Trading - FAQ
What is the latest insider trade for RGNX?
REGENXBIO Inc. (RGNX) had 15 insider filings in the last 90 days, with the most recent on 2026-08-27. The full record for RGNX runs to 31 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying RGNX stock?
2 insider purchases of RGNX were filed in the last 90 days, totaling $949K.
How many insiders are selling RGNX stock?
3 insider sales of RGNX were filed in the last 90 days, totaling $718K.
Where can I see RGNX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks RGNX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow RGNX insider buys?
Create a free InsiderAlpha account and press Watch on this page to add RGNX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Gregory Austin Ciongoli view on EDGAR
- - Steve Pakola view on EDGAR
- - Patrick J. Christmas view on EDGAR
- - Curran Simpson view on EDGAR
- - Steve Pakola view on EDGAR
- - Steve Pakola view on EDGAR
- - Daniel Tasse view on EDGAR
- - David C. Stump view on EDGAR
- - Jennifer Zachary view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where RGNX's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track RGNX insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
